πŸ‡ΊπŸ‡Έ FDA
Patent

US 7537759

Modulating angiogenesis

granted A61KA61K2039/505A61K31/198

Quick answer

US patent 7537759 (Modulating angiogenesis) held by The Regents of the University of California expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505, A61K31/198, A61K31/381, A61K31/405